Park Dental Partners, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated December 4, 2025, details the completion of the Initial Public Offering (IPO) of Park Dental Partners, Inc., a Minnesota-based dental services company. The report covers the pricing of the offering on December 2, 2025, and the closing of the transaction on December 4, 2025. The Company is classified as an emerging growth company.
Key Financial Metrics and Transaction Details
- Offering Price: $13.00 per share.
- Shares Sold: 1,535,000 shares of Common Stock.
- Underwriting Discount: 7% of the IPO price ($0.91 per share).
- Warrant Issuance: A warrant to purchase 6.0% of the aggregate shares sold in the IPO (92,100 shares) was issued to the representative underwriter.
- Warrant Terms: Exercisable at 120% of the IPO price ($15.60) on a cashless basis for a five-year period.
- Over-Allotment Option: Underwriters were granted a 30-day option to purchase up to an additional 230,250 shares.
- Lock-Up Period: A 180-day restriction applies to the sale or transfer of the Warrant and underlying shares.
Note: This filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the Company. Those metrics are typically found in the referenced Form S-1 Registration Statement.
Material Changes
The primary material change reported is the transition of the Company from a private entity to a publicly traded company on The Nasdaq Stock Market LLC under the trading symbol "PARK". This event resulted in the issuance of new equity and the establishment of underwriting agreements and warrant obligations.
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, management commentary on future performance, or a detailed risk factor section. However, it notes customary provisions regarding the use of proceeds and compliance with applicable laws. The filing explicitly states that press releases attached as exhibits are not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the final number of shares sold, including any exercise of the 30-day over-allotment option.
- Review the full Form S-1 Registration Statement (File No. 333-290001) for audited financial statements, revenue trends, and risk factors not included in this 8-K.
- Confirm the exact use of proceeds from the IPO as detailed in the Registration Statement.
- Monitor the 180-day lock-up expiration date for potential market impact from the release of restricted shares.